Literature DB >> 12566888

Ocular blood flow in healthy and primary open-angle glaucomatous eyes.

Hakki Birinci1, Murat Danaci, Ihsan Oge, N Dilek Erkan.   

Abstract

PURPOSE: To evaluate blood flow parameters in the ophthalmic artery, in the posterior ciliary arteries and in the central retinal artery in eyes with primary open-angle glaucoma.
METHODS: Hemodynamic parameters were evaluated by color Doppler imaging in 48 patients with primary open-angle glaucoma and 42 age-matched normal control subjects. Peak systolic velocity (Pv), end-diastolic velocity (Ev), and resistive index (RI) were calculated in the central retinal artery, short posterior ciliary arteries and the ophthalmic artery.
RESULTS: The analysis of the ocular blood flow velocities in the central retinal artery, short posterior ciliary arteries and the ophthalmic artery revealed a significant reduction in peak systolic velocity and end-diastolic velocity with an increase in resistive index in primary open-angle glaucoma compared with controls (p < 0.05).
CONCLUSION: Our data indicate primary open-angle glaucoma to be associated with a decreased flow velocity and increased resistive index in the ocular vasculature. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2002        PMID: 12566888     DOI: 10.1159/000067553

Source DB:  PubMed          Journal:  Ophthalmologica        ISSN: 0030-3755            Impact factor:   3.250


  10 in total

1.  Retrobulbar haemodynamics and morphometric optic disc analysis in primary open-angle glaucoma.

Authors:  N Plange; M Kaup; A Weber; K O Arend; A Remky
Journal:  Br J Ophthalmol       Date:  2006-08-16       Impact factor: 4.638

2.  Color Doppler imaging in optic neuritis with multiple sclerosis.

Authors:  Cengiz Akarsu; Funda Uysal Tan; Tuba Kendi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-07-15       Impact factor: 3.117

Review 3.  Ocular hemodynamics and glaucoma: the role of mathematical modeling.

Authors:  Alon Harris; Giovanna Guidoboni; Julia C Arciero; Annahita Amireskandari; Leslie A Tobe; Brent A Siesky
Journal:  Eur J Ophthalmol       Date:  2013 Mar-Apr       Impact factor: 2.597

4.  Ocular pulse amplitude and retrobulbar blood flow change in dipper and non-dipper individuals.

Authors:  R Karadag; U C Keskin; A Koktener; Y Selcoki; I F Hepsen; M Kanbay
Journal:  Eye (Lond)       Date:  2011-03-18       Impact factor: 3.775

5.  Color Doppler imaging in ocular hypertension and open-angle glaucoma.

Authors:  Cengiz Akarsu; M Yasemin Karadeniz Bilgili
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-12-09       Impact factor: 3.117

6.  Predictive value of retrobulbar blood flow velocities in glaucoma suspects.

Authors:  Pilar Calvo; Antonio Ferreras; Vicente Polo; Noemi Güerri; Pilar Seral; Isabel Fuertes-Lazaro; Luis E Pablo
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-06-22       Impact factor: 4.799

7.  Role of color Doppler imaging in early diagnosis and prediction of progression in glaucoma.

Authors:  Fatima Jimenez-Aragon; Elena Garcia-Martin; Raquel Larrosa-Lopez; Jose M Artigas-Martín; Pilar Seral-Moral; Luis E Pablo
Journal:  Biomed Res Int       Date:  2013-09-17       Impact factor: 3.411

Review 8.  Ocular blood flow and cerebrospinal fluid pressure in glaucoma.

Authors:  Véronique Promelle; Joël Daouk; Roger Bouzerar; Benjamin Jany; Solange Milazzo; Olivier Balédent
Journal:  Acta Radiol Open       Date:  2016-02-12

9.  Paired Optic Nerve Microvasculature and Nailfold Capillary Measurements in Primary Open-Angle Glaucoma.

Authors:  Marissa K Shoji; Clara C Cousins; Chhavi Saini; Rafaella Nascimento E Silva; Mengyu Wang; Stacey C Brauner; Scott H Greenstein; Louis R Pasquale; Lucy Q Shen
Journal:  Transl Vis Sci Technol       Date:  2021-06-01       Impact factor: 3.283

10.  Color Doppler imaging analysis of retrobulbar blood flow velocities in primary open-angle glaucomatous eyes: a meta-analysis.

Authors:  Nana Meng; Ping Zhang; Huadong Huang; Jinlan Ma; Yue Zhang; Hao Li; Yi Qu
Journal:  PLoS One       Date:  2013-05-13       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.